ZSWIM5: A Potential Drug Target and Biomarker (G57643)

Target Name: ZSWIM5

NCBI ID: G57643

ZSWIM5

ZSWIM5: A Potential Drug Target and Biomarker

Zinc finger SWIM-type containing 5 (ZSWIM5) is a protein that has been identified as a potential drug target and biomarker in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. ZSWIM5 is a unique protein that is expressed in various tissues and organs, including the brain, spinal cord, heart, kidneys, and liver. Its unique structure and function make it an attractive target for drug development.

The Zinc Finger is a protein that is considered a potential drug target (or biomarker) in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. ZSWIM5 is a unique protein expressed in a variety of tissues and organs, including the brain, spinal cord, heart, kidney and liver. Its unique structure and function make it an attractive drug target (or biomarker) target.

ZSWIM5 has been shown to play a crucial role in various physiological processes in the body, including cell signaling, inflammation, and fibrosis. It has been shown to promote the development of cancer, and it is also a strong predictor of cancer-related mortality. ZSWIM5 has also been linked to a number of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

ZSWIM5 is a unique protein that is expressed in various tissues and organs, including the brain, spinal cord, heart, kidneys, and liver. Its unique structure and function make it an attractive target for drug development. Studies have shown that ZSWIM5 can interact with a variety of molecules, including transcription factors, DNA-binding proteins, and signaling molecules.

One of the most promising aspects of ZSWIM5 is its potential as a drug target. ZSWIM5 has been shown to interact with a variety of signaling molecules, including TGF-β1, PDGF, and NF-kappa-B. These signaling molecules are involved in a wide range of physiological processes, including cell growth, differentiation, and inflammation. By targeting these molecules, researchers believe that they may be able to develop drugs that can treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Another promising aspect of ZSWIM5 is its potential as a biomarker. ZSWIM5 has been shown to be highly expressed in a variety of cancer types, including breast, ovarian, and colorectal cancers. This makes it an attractive target for cancer diagnostic and prognostic tools. Additionally , ZSWIM5 has been shown to be highly expressed in neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. This makes it an attractive target for diagnostic tools and therapies for these diseases.

In conclusion, ZSWIM5 is a unique protein that has been shown to play a crucial role in various physiological processes in the body. Its unique structure and function make it an attractive target for drug development and biomarker research. Further studies are needed to fully understand the role of ZSWIM5 in diseases and to develop effective treatments.

Protein Name: Zinc Finger SWIM-type Containing 5

The "ZSWIM5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZSWIM5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets